Global WACh

Research


December 2, 2024

Enterics for Global Health (EFGH) Phase C aims to assess policymaker preferences on Shigella vaccine characteristics

Categories: , , ,

The Enterics for Global Health (EFGH): Shigella surveillance study was launched in 2022 and aims to establish incidence and consequences of Shigella diarrhea among children 6-35 months in Bangladesh, Kenya, Malawi, Mali, Pakistan, Peru, and The Gambia and inform future Shigella vaccine trial planning. The study protocol has been published in a supplement in Open Forum of Infectious Diseases. During Phases A and B, the EFGH Consortium built a robust collaborative research infrastructure to facilitate shared scientific decision making and protocol standardization, and recently completed enrollment of 9,476 participants in August 2024.
(more…)


November 27, 2024

Enterics for Global Health (EFGH) Symposium hosted at the American Society of Tropical Medicine & Hygiene annual meeting

Categories: , ,

Investigators from the Enterics for Global Health (EFGH) Consortium presented preliminary study results at the annual meeting of The American Society of Tropical Medicine & Hygiene in New Orleans, Louisiana from November 13th-17th, 2024.

The symposium was titled: “Preliminary results from The Enterics for Global Health (EFGH) Shigella surveillance study- preparing for Shigella vaccine trials in the target population of young children living in low- and middle-income countries” and aimed to: (more…)


Researchers awarded new grant to test implementation strategies to scale-up transitional care among youth living with HIV in Kenya

Categories: , ,


As more children and adolescents living with HIV survive into adulthood, maintaining successful and uninterrupted transitions into adult HIV care clinics has become a priority in the HIV/AIDS research community.  Adolescents having “grown up” under pediatric HIV care may experience deep loss of their support system and feel less prepared to assume responsibility for themselves in adult care.  The transition is a vulnerable point when adolescents are at risk of disengagement from HIV care altogether.  It is critical that they maintain uninterrupted HIV care to stay healthy, maintain low viral load, and reduce further transmission.

Since 2016, Global WACh investigators Drs. Irene Njuguna, Kristin Beima-Sofie, Grace John-Stewart, and Dalton Wamalwa have led efforts to engage the Ministry of Health and local communities in Kenya in the development of the Adolescent Transition Package (ATP), a healthcare worker toolkit that includes structured educational materials and tracking tools to facilitate the transition process. (more…)


November 26, 2024

Dr. Arianna Means awarded grant to develop a researcher-friendly tool to improve translating evidence into practice

Categories: , ,

It is estimated that it takes an average of 17 years for 14% of clinical research to translate into practice. Many evidence-based interventions (EBIs), including biomedical interventions or practices that have demonstrated ability to improve health behaviors, health outcomes, or health-related environments, fail to translate into policy and practice.

There are several cultural, organizational, political and operational barriers that prevent effective uptake of EBIs.  There may be serious constraints in policymakers’ preferences and priorities, the ability to supply the workforce training needed, and communication gaps between researchers and policymakers, among many other factors.

Dr. Arianna Means, Assistant Professor in UW Global Health, who is a trained epidemiologist and implementation scientist, is launching a new project in early 2025 to help close the gap between what scientists know can optimize health and what they do in practice (often referred to as “the know-do gap”) by identifying and addressing the barriers that slow or halt the uptake of EBIs. (more…)


November 20, 2024

Global WACh Certificate Student Emmalie Griswold supports new study to help describe decision-making processes of people living in US states with poor abortion access

Categories: , , ,

Since the US Supreme Court Dobbs decision in June 2022 to take away the constitutional right to abortion, more than 20 US states ban or severely restrict abortion care. Consequently, about 1 in 5 seeking abortion travel across state lines, impeding access to timely and affordable care. Understanding the decision-making, journeys and care received by out-of-state patients seeking in-person care in legal states is urgently needed to improve equitable access to abortion.

The UW Access, Delivered research team, based in the Department of Family Medicine Women’s Health Research and Scholarship Lab, recently launched a new study aimed at understanding the decision-making processes of individuals living in states with severe abortion restrictions, who either choose to order medication abortion pills through an online provider or pursue in-person care in another state. The team is partnering with three clinics providing first-trimester abortion care (two in-person and one virtual), and engaging a diverse six-person Community Advisory Board. The evidence generated can inform patient-facing decision-making tools for people living in areas with poor abortion access.

During Summer 2024, Emmalie Griswold, a 2nd year MPH in Health Systems and Population Health (HSPOP) and Global WACh Graduate Certificate student, provided critical research coordination support to set up the research infrastructure of the new study, essentially laying the groundwork for smooth study execution.  (more…)


November 19, 2024

Global WACh Certificate Student Amaya Gatling supports neonatal health researchers identify pathways to implement a smartphone-based birth asphyxia screening tool for newborns

Categories: , , ,

Birth asphyxia affects nearly 30 per 1,000 live births in low-income countries worldwide. Birth asphyxia accounts for almost a quarter of neonatal deaths and remains a significant contributor to long-term disability worldwide. Early identification of infants at highest risk is necessary to improve short- and long-term outcomes. Standardized measurements to objectively assess a newborn’s risk are often unavailable in low resource settings due to lack of human resources and high cost.

With support from the UW Population Health Social Entrepreneur Fellowship Program, a project team in UW Pediatrics Division of Neonatology is working to solve this issue by developing a portable, affordable device for blood pH measurement and screening in low-income countries. The device, named pHastCam, will utilize a pH sensitive dye and ubiquitous smartphone camera technology to determine blood pH within seconds.

In Summer 2024, the program assigned Amaya Gatling, 2nd year MPH in Global Health and Global WACh Graduate Certificate student, to support the pHastCam team, led by Drs. Krystle Perez and Gregory Valentine, by conducting a deep dive into customer discovery, market strategy and explore how to build a pathway to sustainability in low-income countries.  (more…)


October 7, 2024

Laurén Gómez awarded IAS New Investigator Award for research identifying motivators of initiating PrEP in pregnancy

Categories: , , ,

Congratulations to Laurén Gómez, Senior Research Coordinator with Global WACh and current PhD student in UW Epidemiology, for receiving the International AIDS Society’s (IAS) New Investigator Award in PrEP and ARV-based prevention research for the abstract, Motivations of pregnant women initiating PrEP within antenatal care enrolled in a randomized trial to improve adherence: the mWACh-PrEP study.”

The award recognized six early-career investigators who presented top-rated work at HIVR4P, the 5th HIV Research for Prevention Conference, held from October 6-10, 2024 in Lima, Peru and virtually. (more…)


Dr. John Kinuthia and Julia Dettinger receive IAS award for high-impact paper on PrEP delivery during pregnancy

Categories: , , ,

Congratulations to Dr. John Kinuthia (Affiliate Associate Professor, UW Global Health; Head of Research and Programs, Kenyatta National Hospital) and Julia Dettinger (former Research Scientist with Global WACh) for receiving the Journal of the International AIDS Society’s (JIAS) HIV Prevention Impact Award for the co-authored article, “Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019.”

The award was announced at HIVR4P, the 5th HIV Research for Prevention Conference, held from October 6-10, 2024 in Lima, Peru and virtually. (more…)


August 29, 2024

New study aims to evaluate a novel pediatric TB diagnostic tool and treatment response

Categories: , ,

Investigators Dr. Sylva LaCourse (UW), Dr. Tony Hu (Tulane University), and Dr. Vidalis Nduba (KEMRI CRDR)

Young children account for 50% of pediatric tuberculosis (TB) cases but are least likely to be diagnosed and are at the highest risk of death without prompt treatment. Current available diagnostics – typically sputum-based – often fail to identify TB in children and are generally not reliable for measuring treatment response. There is a need to develop and evaluate novel diagnostic tools utilizing blood and urine, which may identify pediatric TB missed by respiratory sampling.

A new five-year study titled “CRISPR-TB for pediatric TB diagnosis and treatment response” funded by the National Institutes of Health will support an evaluation of a CRISPR-based technology to target and detect Mycobacterium tuberculosis cell-free DNA (cfDNA). The study’s findings may provide a deeper understanding of its potential to diagnosis pediatric TB early and accurately and improve treatment responses. (more…)


August 27, 2024

New award will support building pre-award research administration capacity at Kenyatta National Hospital in Kenya

Categories: ,

Credit: Karolina Kaboompics/Pexels

Congratulations to the research administrative team at Kenyatta National Hospital (KNH) and UW/Global WACh for receiving a National Institute of Allergy and Infectious Diseases (NIAID) G11 award to build pre-award grants management processes at KNH by leveraging an over 30 years long collaborative research partnership between KNH and UW. (more…)



Next page